Atlas Trials

Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer

Clinical trial NCT00691730 · COMPLETED

Trial details

NCT number
NCT00691730
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2008-02-01
Primary completion
2012-07-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.